Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 18, 2025
Bromelain enhances nitric oxide bioavailability: Bradykinin's link to TRPV1/Ca2+ /AMPK/autophagy signalingWen-Hua Chen, Yi-Ying Wu, Man-Chen Hsu, et al.
Journal of Epidemiology|February 1, 2017
Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancerAmy Ming-Fang Yen, Wendy Yi-Ying Wu, Laszlo Tabar, et al.
Life Sciences|May 1, 2014
Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stagesYao Xiong, Yuan-Yuan Zhang, Yi-Ying Wu, et al.
Oncotarget|June 7, 2018
Premorbid BMI as a prognostic factor in small-cell lung cancer-a single institute experienceCho-Hao Lee, Chin Lin, Chieh-Yung Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2025
Pre-diagnostic serum immune marker levels and multiple myeloma: A prospective longitudinal study using samples from the Janus Serum Bank in NorwaySimona Herdenberg, Carl Wibom, Esmeralda J M Krop, et al.
Nature Communications|October 28, 2017
The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotencyChun-Ying Yu, Tung-Cheng Li, Yi-Ying Wu, et al.
Journal of Clinical Medicine|May 26, 2019
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-AnalysisPo-Huang Chen, Ching-Liang Ho, Chin Lin, et al.
Frontiers in Public Health|April 11, 2022
Application and Evaluation of the Flipped Classroom Based on Micro-Video Class in Pharmacology TeachingYi-Ying Wu, Sha Liu, Qiong Man, et al.
Medicine|March 30, 2020
Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysisCho-Hao Lee, Yi-No Kang, Ching-Liang Ho, et al.
Cell Biology International|July 17, 2022
Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathwayLin Zhu, Sha Liu, Yi-Fan Liao, et al.
Pageof 21